These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 12781882)
1. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Urschel JD; Vasan H Am J Surg; 2003 Jun; 185(6):538-43. PubMed ID: 12781882 [TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Urschel JD; Vasan H; Blewett CJ Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125 [TBL] [Abstract][Full Text] [Related]
3. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. Lv J; Cao XF; Zhu B; Ji L; Tao L; Wang DD World J Gastroenterol; 2009 Oct; 15(39):4962-8. PubMed ID: 19842230 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for resectable esophageal carcinoma: a meta-analysis of randomized clinical trials. Xu XH; Peng XH; Yu P; Xu XY; Cai EH; Guo P; Li K Asian Pac J Cancer Prev; 2012; 13(1):103-10. PubMed ID: 22502650 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. Malthaner RA; Wong RK; Rumble RB; Zuraw L; BMC Med; 2004 Sep; 2():35. PubMed ID: 15447788 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. Jin HL; Zhu H; Ling TS; Zhang HJ; Shi RH World J Gastroenterol; 2009 Dec; 15(47):5983-91. PubMed ID: 20014464 [TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Esophageal Cancer Patients: A Systematic Review and Meta-Analysis. Xiao X; Hong HG; Zeng X; Yang YS; Luan SY; Li Y; Chen LQ; Yuan Y World J Surg; 2020 Dec; 44(12):4161-4174. PubMed ID: 32761259 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials. Kumar T; Pai E; Singh R; Francis NJ; Pandey M World J Surg Oncol; 2020 Mar; 18(1):59. PubMed ID: 32199464 [TBL] [Abstract][Full Text] [Related]
10. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis. Pasquali S; Yim G; Vohra RS; Mocellin S; Nyanhongo D; Marriott P; Geh JI; Griffiths EA Ann Surg; 2017 Mar; 265(3):481-491. PubMed ID: 27429017 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis. Chan KKW; Saluja R; Delos Santos K; Lien K; Shah K; Cramarossa G; Zhu X; Wong RKS Int J Cancer; 2018 Jul; 143(2):430-437. PubMed ID: 29441562 [TBL] [Abstract][Full Text] [Related]
12. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis. Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149 [TBL] [Abstract][Full Text] [Related]
15. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma. Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience. Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients. Samson P; Robinson C; Bradley J; Lockhart AC; Puri V; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Meyers B; Crabtree T J Thorac Oncol; 2016 Dec; 11(12):2227-2237. PubMed ID: 27544058 [TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer. Shinoda M; Hatooka S; Mori S; Mitsudomi T Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291 [TBL] [Abstract][Full Text] [Related]
20. Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis. Qin Q; Xu H; Liu J; Zhang C; Xu L; Di X; Zhang X; Sun X Int J Surg; 2018 Nov; 59():11-18. PubMed ID: 30261331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]